Title : Perioperative management with phosphodiesterase type 5 inhibitor and prostaglandin E1 for moderate portopulmonary hypertension following adult-to-adult living-donor liver transplantation: a case report.

Pub. Date : 2018 Feb 7

PMID : 29417353






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Here, we report on a patient with moderate PPH whose condition was successfully managed with a phosphodiesterase type 5 (PDE5) inhibitor (tadalafil) and prostaglandin E1, who experienced rapid improvement of PPH after living-donor liver transplantation (LDLT). Tadalafil phosphodiesterase 5A Homo sapiens
2 Here, we report on a patient with moderate PPH whose condition was successfully managed with a phosphodiesterase type 5 (PDE5) inhibitor (tadalafil) and prostaglandin E1, who experienced rapid improvement of PPH after living-donor liver transplantation (LDLT). Tadalafil phosphodiesterase 5A Homo sapiens